MoonLake Immunotherapeutics

MLTX

Equity

ISIN KY61559X1045 / Valor 118139749

NASDAQ (2026-04-27)

USD 16.85-1.92%

MoonLake Immunotherapeutics
UMushroom community rating:

4.00 2 votes No rating yet

NegativeNeutralPositive

About company

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory diseases. The company's primary asset is Sonelokimab, an investigational Nanobody® designed to target and treat inflammation more effectively. By leveraging advanced biotechnological approaches, MoonLake aims to improve patient outcomes in conditions characterized by chronic inflammation. The company is dedicated to advancing Sonelokimab through clinical trials to establish its efficacy and safety, positioning itself as a key player in the biopharmaceutical industry’s efforts to address unmet medical needs in inflammatory diseases.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

327%1Y

700%3Y

%5Y

Performance

70.5%1Y

76.0%3Y

87.7%5Y

Volatility

1209 M

Market cap (USD)

480,457

Daily traded volume (Shares)

55.19 / 52.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

2 votes

Performance:

4.50

Innovation:

4.00

Society:

4.00

Nature:

4.00

Alex Roberts

United Kingdom, 17 Dec 2025

Should've listened to this guy -->

Alex Roberts

United Kingdom, 20 Nov 2025

up 40% since I added a month ago, bounce back after potential lawsuit. Potential takeover looming

EQUITIES OF THE SAME SECTOR

Julius Baer Group Ltd.

Julius Baer Group Ltd. Valor: 10248496

Annual Return

-50%0%+50%

Risk level

110

-0.52%CHF 61.56

The Toronto-Dominion Bank

The Toronto-Dominion Bank Valor: 701890

Annual Return

-50%0%+50%

Risk level

110

0.40%CAD 144.14

Valiant Holding AG

Valiant Holding AG Valor: 1478650

Annual Return

-50%0%+50%

Risk level

110

0.22%CHF 183.40

Derwent London PLC REIT

Derwent London PLC REIT Valor: 381696

Annual Return

-50%0%+50%

Risk level

110

-0.17%GBP 17.50

Blue Owl Capital Corporation

Blue Owl Capital Corporation Valor: 48358153

Annual Return

-50%0%+50%

Risk level

110

-0.71%USD 11.19

Evercore Inc

Evercore Inc Valor: 2564420

Annual Return

-50%0%+50%

Risk level

110

1.01%USD 347.79

Terreno Realty Corp

Terreno Realty Corp Valor: 10835338

Annual Return

-50%0%+50%

Risk level

110

1.03%USD 65.95

Essent Group Ltd

Essent Group Ltd Valor: 22389305

Annual Return

-50%0%+50%

Risk level

110

1.08%USD 64.31

Kite Realty Group Trust

Kite Realty Group Trust Valor: 25008577

Annual Return

-50%0%+50%

Risk level

110

0.54%USD 26.11

UMB Financial Corp

UMB Financial Corp Valor: 231889

Annual Return

-50%0%+50%

Risk level

110

1.59%USD 124.16

Logos provided by Clearbit

MoonLake Immunotherapeutics

MLTX

ISIN KY61559X1045 / Valor 118139749

MoonLake Immunotherapeutics UMushroom community rating:

Alex Roberts

Alex Roberts

MoonLake Immunotherapeutics
UMushroom community rating: